ViaLase receives CE Mark for its ViaLase Laser, a femtosecond laser for glaucoma treatment
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, announced that it has received CE (ConformitĂ© EuropĂ©enne) Mark approval in the European Union (EU) for its ViaLase …